NANTWICH HEALTH CENTRE — All Prescriptions & Medications — Page 2
Practice Code: N81010 | NANTWICH, CW5 5NX
Showing results 51-100 of 540
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Candesartan cilexetil | 689 | 21.2K | £1.0K | -41.9% ▼ |
| Amoxicillin | 681 | 39.0K | £903 | -26.9% ▼ |
| Montelukast | 655 | 18.4K | £933 | -4.3% ▼ |
| Edoxaban | 654 | 18.5K | £30.8K | -6.6% ▼ |
| Fexofenadine hydrochloride | 625 | 21.4K | £928 | -26.5% ▼ |
| Lisinopril | 622 | 20.5K | £460 | -43.2% ▼ |
| Duloxetine hydrochloride | 619 | 18.1K | £1.5K | -2.6% ▼ |
| Ezetimibe | 611 | 17.8K | £3.2K | -14.1% ▼ |
| Ferrous sulfate | 593 | 25.6K | £863 | +15.3% ▲ |
| Solifenacin | 571 | 16.8K | £640 | +19.7% ▲ |
| Other emollient preparations | 569 | 330.0K | £4.1K | -5.3% ▼ |
| Mometasone furoate | 561 | 566 | £4.4K | +39.7% ▲ |
| 554 | 286.9K | £3.1K | +110.0% ▲ | |
| Isosorbide mononitrate | 550 | 14.5K | £3.3K | -16.8% ▼ |
| Carbocisteine | 542 | 78.1K | £2.3K | +1.5% vs avg |
| Co-codamol (Codeine phosphate/paracetamol) | 513 | 25.9K | £869 | -73.8% ▼ |
| Pregabalin | 513 | 30.4K | £3.9K | -59.1% ▼ |
| Doxycycline hyclate | 503 | 6,188 | £632 | -1.9% vs avg |
| Lamotrigine | 502 | 24.3K | £5.5K | -15.0% ▼ |
| Pravastatin sodium | 481 | 13.8K | £656 | +48.1% ▲ |
| Prednisolone | 470 | 20.7K | £640 | -41.2% ▼ |
| Irbesartan | 448 | 14.4K | £522 | +83.9% ▲ |
| Escitalopram | 436 | 12.1K | £754 | +53.2% ▲ |
| Alginic acid compound preparations | 431 | 215.2K | £3.5K | -26.4% ▼ |
| 431 | 882 | £28.5K | -20.9% ▼ | |
| Hydrocortisone | 417 | 13.4K | £3.4K | -7.0% ▼ |
| Progesterone | 399 | 30.1K | £5.5K | -4.7% ▼ |
| Paroxetine hydrochloride | 393 | 12.3K | £458 | +110.6% ▲ |
| Glucose blood testing reagents | 393 | 36.2K | £5.6K | -50.2% ▼ |
| Codeine phosphate | 385 | 20.5K | £679 | -46.4% ▼ |
| Betamethasone valerate | 382 | 34.2K | £2.4K | -0.8% vs avg |
| Digoxin | 374 | 11.0K | £803 | -1.2% vs avg |
| 372 | 203.8K | £2.1K | -62.2% ▼ | |
| Flucloxacillin sodium | 371 | 17.6K | £898 | -17.5% ▼ |
| Insulin aspart | 370 | 2,733 | £17.1K | -2.8% ▼ |
| Budesonide | 368 | 5,538 | £8.6K | -32.1% ▼ |
| Desogestrel | 368 | 46.5K | £1.6K | -7.2% ▼ |
| Gabapentin | 359 | 34.2K | £860 | -64.1% ▼ |
| Pioglitazone hydrochloride | 355 | 19.5K | £735 | +301.5% ▲ |
| Mesalazine (Systemic) | 354 | 35.2K | £16.3K | +47.8% ▲ |
| Felodipine | 354 | 10.1K | £1.4K | -40.4% ▼ |
| Loratadine | 350 | 11.8K | £282 | +67.5% ▲ |
| Fluticasone/umeclidinium/vilanterol | 345 | 351 | £14.8K | +47.2% ▲ |
| Diltiazem hydrochloride | 344 | 13.5K | £2.7K | +12.0% ▲ |
| Naproxen | 338 | 17.2K | £1.4K | -65.8% ▼ |
| Levetiracetam | 336 | 36.8K | £3.1K | -26.6% ▼ |
| Bendroflumethiazide | 329 | 9,380 | £151 | -57.5% ▼ |
| Nefopam hydrochloride | 328 | 20.0K | £871 | +190.0% ▲ |
| Sumatriptan succinate | 325 | 2,570 | £9.5K | -8.2% ▼ |
| Bumetanide | 323 | 17.0K | £1.7K | +18.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.